Medicine and Healthnpj Vaccines
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection
K. A. Holder, D. P. Ings, et al.
Discover how the severity of SARS-CoV-2 infections influences vaccine-induced immune responses in this intriguing study conducted by Kayla A. Holder, Danielle P. Ings, Debbie O. A. Harmun, Rodney S. Russell, and Michael D. Grant. The research reveals that moderate/severe cases maintain stronger immune responses post-vaccination, underscoring the importance of infection severity in vaccination strategies.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples
O. A. Pipek, A. Medgyes-horváth, et al.
Medicine and Health
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
L. Pérez-alós, C. B. Hansen, et al.
Biology
Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity
Silva-moraes, Souquette, et al.
Biology
The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
A. M. Buck, A. N. Deitchman, et al.
